Proteomic Analysis of Early Mid-Trimester Amniotic Fluid Does Not Predict Spontaneous Preterm Delivery

Objective The aim of this study was to identify early proteomic biomarkers of spontaneous preterm delivery (PTD) in mid-trimester amniotic fluid from asymptomatic women. Methods This is a case-cohort study. Amniotic fluid from mid-trimester genetic amniocentesis (14–19 weeks of gestation) was collected from 2008 to 2011. The analysis was conducted in 24 healthy women with subsequent spontaneous PTD (cases) and 40 randomly selected healthy women delivering at term (controls). An exploratory phase with proteomics analysis of pooled samples was followed by a verification phase with ELISA of individual case and control samples. Results The median (interquartile range (IQR: 25th; 75th percentiles) gestational age at delivery was 35+5 (33+6–36+6) weeks in women with spontaneous PTD and 40+0 (39+1–40+5) weeks in women who delivered at term. In the exploratory phase, the most pronounced differences were found in C-reactive protein (CRP) levels, that were approximately two-fold higher in the pooled case samples than in the pooled control samples. However, we could not verify these differences with ELISA. The median (25th; 75th IQR) CRP level was 95.2 ng/mL (64.3; 163.5) in women with spontaneous PTD and 86.0 ng/mL (51.2; 145.8) in women delivering at term (p = 0.37; t-test). Conclusions Proteomic analysis with mass spectrometry of mid-trimester amniotic fluid suggests CRP as a potential marker of spontaneous preterm delivery, but this prognostic potential was not verified with ELISA.

[1]  S. Kim,et al.  Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study , 2015, Journal of Perinatology.

[2]  M. Torloni,et al.  Proteomic Biomarkers for Spontaneous Preterm Birth , 2014, Reproductive Sciences.

[3]  A. Vlahou,et al.  Clinical proteomics in obstetrics and neonatology , 2014, Expert review of proteomics.

[4]  J. Shin,et al.  Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. , 2013, Placenta.

[5]  R. Menon,et al.  Proteomics and bioinformatics analysis reveal underlying pathways of infection associated histologic chorioamnionitis in pPROM. , 2013, Placenta.

[6]  K. Kalache,et al.  Proteomic analysis of midtrimester amniotic fluid to identify novel biomarkers for preterm delivery , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[7]  M. Kacerovsky,et al.  Amniotic Fluid Cathelicidin in PPROM Pregnancies: From Proteomic Discovery to Assessing Its Potential in Inflammatory Complications Diagnosis , 2012, PloS one.

[8]  Noelia Dasilva,et al.  Biomarker Discovery by Novel Sensors Based on Nanoproteomics Approaches , 2012, Sensors.

[9]  M. Dombrowski,et al.  The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes. , 2012, American journal of obstetrics and gynecology.

[10]  B. Jacobsson,et al.  Soluble Toll-like receptor 1 family members in the amniotic fluid of women with preterm prelabor rupture of the membranes , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[11]  Chengcheng Hu,et al.  Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition , 2011, Clinical chemistry and laboratory medicine.

[12]  Stephen R Master,et al.  Isobaric labeling and tandem mass spectrometry: A novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[13]  M. Kacerovsky,et al.  Application of proteomics in biomarker discovery: a primer for the clinician. , 2010, Physiological research.

[14]  A. Abdollahi,et al.  Mid‐trimester amniotic fluid C‐reactive protein, ferritin and lactate dehydrogenase concentrations and subsequent risk of spontaneous preterm labour , 2009, Australian and New Zealand journal of obstetrics and gynaecology.

[15]  S. Foster-Cohen,et al.  Very preterm children show impairments across multiple neurodevelopmental domains by age 4 years , 2009, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[16]  V. Bhandari,et al.  Fetal inflammatory response in women with proteomic biomarkers characteristic of intra‐amniotic inflammation and preterm birth , 2009, BJOG : an international journal of obstetrics and gynaecology.

[17]  C. Buhimschi,et al.  Multidimensional Proteomics Analysis of Amniotic Fluid to Provide Insight into the Mechanisms of Idiopathic Preterm Birth , 2008, PloS one.

[18]  Gary D. Stormo,et al.  A global approach to identify differentially expressed genes in cDNA (two-color) microarray experiments , 2007, Bioinform..

[19]  V. Bhandari,et al.  Proteomic Profiling of the Amniotic Fluid to Detect Inflammation, Infection, and Neonatal Sepsis , 2007, PLoS medicine.

[20]  Gerard Tromp,et al.  The use of high‐dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome , 2006, BJOG : an international journal of obstetrics and gynaecology.

[21]  T. Pekin,et al.  Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[22]  Henrik Zetterberg,et al.  Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. , 2005, Journal of proteome research.

[23]  B. Jacobsson,et al.  Preterm birth in Sweden 1973–2001: Rate, subgroups, and effect of changing patterns in multiple births, maternal age, and smoking , 2005, Acta obstetricia et gynecologica Scandinavica.

[24]  Robert E Black,et al.  WHO estimates of the causes of death in children , 2005, The Lancet.

[25]  C. Buhimschi,et al.  Proteomic biomarker analysis of amniotic fluid for identification of intra‐amniotic inflammation , 2005, BJOG : an international journal of obstetrics and gynaecology.

[26]  N. Sezgin,et al.  Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery? , 2005, Journal of perinatal medicine.

[27]  J. Lapidus,et al.  Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. , 2004, JAMA.

[28]  B. Dastugue,et al.  Identification of biologic markers of the premature rupture of fetal membranes: Proteomic approach , 2003, Proteomics.

[29]  J. Hauth,et al.  Choriodecidual infection and preterm birth. , 2002, Nutrition reviews.

[30]  F. Ghezzi,et al.  Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. , 2002, American journal of obstetrics and gynecology.

[31]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[32]  F. Ghezzi,et al.  Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. , 1995, Clinics in perinatology.